Skip to content

Author

S. Balmagambetova

We have 3 of 37 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Risk-stratified changes in left atrial strain during chemotherapy: preliminary data

LAS analysis provides complementary information for early cardiac functional assessment in cardio-oncology beyond conventional ventricular indices, and exhibits dynamic changes during chemotherapy with distinct risk-dependent patterns.

B. Zholdin, A. Amanova, S. Balmagambetova et al. · 0 citations
Aug 2026

A structured clinical decision support tool for cardiovascular risk stratification and longitudinal monitoring during anthracycline and HER2-targeted therapy

Translating the 2022 ESC cardio-oncology recommendations into a structured clinical decision support tool may facilitate standardized cardiovascular assessment and risk-adapted monitoring in patients receiving potentially cardiotoxic cancer therapy. To develop and present a structured clinical decision sup...

Y. Kulmukhanov, Z. Tlegenova, A. Amanova et al. · 0 citations
Aug 2026

Right ventricular strain dynamics during anthracycline therapy in breast cancer patients stratified by cardiotoxicity risk: preliminary results

It is suggested that RV strain assessment provides information complementary to conventional LV–based cardiotoxicity criteria and may occur in the absence of concurrent changes in conventional LV cardiotoxicity parameters as currently defined.

Z. Tlegenova, A. Amanova, S. Balmagambetova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.